Strategies to Prevent or Remediate Cancer and Treatment-Related Aging

Jennifer L. Guida; Tanya Agurs-Collins; Tim A. Ahles; Judith Campisi; William Dale; Wendy Demark-Wahnefried; Jorg Dietrich; Rebecca Fuldner; Lisa Gallicchio; Paige A. Green; Arti Hurria; Michelle C. Janelsins; Chamelli Jhappan; James L. Kirkland; Ronald Kohanski; Valter Longo; Simin Meydani; Supriya Mohile; Laura J. Niedernhofer; Christian Nelson; Frank Perna; Keri Schadler; Jessica M. Scott; Jennifer A. Schrack; Russell P. Tracy; Jan Van Deursen; Kirsten K. Ness

doi:10.1093/jnci/djaa060

Strategies to Prevent or Remediate Cancer and Treatment-Related Aging

Jennifer L. Guida, Tanya Agurs-Collins, Tim A. Ahles, Judith Campisi, William Dale, Wendy Demark-Wahnefried, Jorg Dietrich, Rebecca Fuldner, Lisa Gallicchio, Paige A. Green, Arti Hurria, Michelle C. Janelsins, Chamelli Jhappan, James L. Kirkland, Ronald Kohanski, Valter Longo, Simin Meydani, Supriya Mohile, Laura J. Niedernhofer, Christian NelsonFrank Perna, Keri Schadler, Jessica M. Scott, Jennifer A. Schrack, Russell P. Tracy, Jan Van Deursen, Kirsten K. Ness

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Abstract

Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.

Original language	English (US)
Pages (from-to)	112-122
Number of pages	11
Journal	Journal of the National Cancer Institute
Volume	113
Issue number	2
DOIs	https://doi.org/10.1093/jnci/djaa060
State	Published - Apr 29 2020

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health (R01CA172119, R01CA129769, U54CA137788, R01CA218496, R01CA129769, and P30CA008748 to TAA; R21/R33AG059206 to WD, SGM, and AH; DP2CA195765 and R01CA231014 to MCJ; R37AG013925 and R33AG061456 to JLK; P01AG062413 to JLK and LJN; P30AG021334, U01AG020478, U01AG020487, U01AG020480 to SNM; K24AG056589 to SGM; AG043376 and AG056278 LJN; R21CA218732 to KS; R21AG053198 and U01AG057545 to JAS; P30CA008748 to JMS; and R01AG052964 to RT), USDA (Agreement # 58-1950-0-014 and 58-805-9-004 to SNM), the American Cancer Society (CRP 14-111-01-CPPB to WDW), and AKTIV Against Cancer (JMS).

Publisher Copyright:
© 2020 Published by Oxford University Press.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1093/jnci/djaa060

Find It

Find It at U of M Libraries

Cite this

Guida, J. L., Agurs-Collins, T., Ahles, T. A., Campisi, J., Dale, W., Demark-Wahnefried, W., Dietrich, J., Fuldner, R., Gallicchio, L., Green, P. A., Hurria, A., Janelsins, M. C., Jhappan, C., Kirkland, J. L., Kohanski, R., Longo, V., Meydani, S., Mohile, S., Niedernhofer, L. J., ... Ness, K. K. (2020). Strategies to Prevent or Remediate Cancer and Treatment-Related Aging. Journal of the National Cancer Institute, 113(2), 112-122. https://doi.org/10.1093/jnci/djaa060

Guida, JL, Agurs-Collins, T, Ahles, TA, Campisi, J, Dale, W, Demark-Wahnefried, W, Dietrich, J, Fuldner, R, Gallicchio, L, Green, PA, Hurria, A, Janelsins, MC, Jhappan, C, Kirkland, JL, Kohanski, R, Longo, V, Meydani, S, Mohile, S, Niedernhofer, LJ, Nelson, C, Perna, F, Schadler, K, Scott, JM, Schrack, JA, Tracy, RP, Van Deursen, J & Ness, KK 2020, 'Strategies to Prevent or Remediate Cancer and Treatment-Related Aging', Journal of the National Cancer Institute, vol. 113, no. 2, pp. 112-122. https://doi.org/10.1093/jnci/djaa060

@article{407ce127d2bf4d2caff22e84ab787172,

title = "Strategies to Prevent or Remediate Cancer and Treatment-Related Aging",

abstract = "Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.",

author = "Guida, {Jennifer L.} and Tanya Agurs-Collins and Ahles, {Tim A.} and Judith Campisi and William Dale and Wendy Demark-Wahnefried and Jorg Dietrich and Rebecca Fuldner and Lisa Gallicchio and Green, {Paige A.} and Arti Hurria and Janelsins, {Michelle C.} and Chamelli Jhappan and Kirkland, {James L.} and Ronald Kohanski and Valter Longo and Simin Meydani and Supriya Mohile and Niedernhofer, {Laura J.} and Christian Nelson and Frank Perna and Keri Schadler and Scott, {Jessica M.} and Schrack, {Jennifer A.} and Tracy, {Russell P.} and {Van Deursen}, Jan and Ness, {Kirsten K.}",

note = "Funding Information: This work was supported by the National Institutes of Health (R01CA172119, R01CA129769, U54CA137788, R01CA218496, R01CA129769, and P30CA008748 to TAA; R21/R33AG059206 to WD, SGM, and AH; DP2CA195765 and R01CA231014 to MCJ; R37AG013925 and R33AG061456 to JLK; P01AG062413 to JLK and LJN; P30AG021334, U01AG020478, U01AG020487, U01AG020480 to SNM; K24AG056589 to SGM; AG043376 and AG056278 LJN; R21CA218732 to KS; R21AG053198 and U01AG057545 to JAS; P30CA008748 to JMS; and R01AG052964 to RT), USDA (Agreement # 58-1950-0-014 and 58-805-9-004 to SNM), the American Cancer Society (CRP 14-111-01-CPPB to WDW), and AKTIV Against Cancer (JMS). Publisher Copyright: {\textcopyright} 2020 Published by Oxford University Press.",

year = "2020",

month = apr,

day = "29",

doi = "10.1093/jnci/djaa060",

language = "English (US)",

volume = "113",

pages = "112--122",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Strategies to Prevent or Remediate Cancer and Treatment-Related Aging

AU - Guida, Jennifer L.

AU - Agurs-Collins, Tanya

AU - Ahles, Tim A.

AU - Campisi, Judith

AU - Dale, William

AU - Demark-Wahnefried, Wendy

AU - Dietrich, Jorg

AU - Fuldner, Rebecca

AU - Gallicchio, Lisa

AU - Green, Paige A.

AU - Hurria, Arti

AU - Janelsins, Michelle C.

AU - Jhappan, Chamelli

AU - Kirkland, James L.

AU - Kohanski, Ronald

AU - Longo, Valter

AU - Meydani, Simin

AU - Mohile, Supriya

AU - Niedernhofer, Laura J.

AU - Nelson, Christian

AU - Perna, Frank

AU - Schadler, Keri

AU - Scott, Jessica M.

AU - Schrack, Jennifer A.

AU - Tracy, Russell P.

AU - Van Deursen, Jan

AU - Ness, Kirsten K.

N1 - Funding Information: This work was supported by the National Institutes of Health (R01CA172119, R01CA129769, U54CA137788, R01CA218496, R01CA129769, and P30CA008748 to TAA; R21/R33AG059206 to WD, SGM, and AH; DP2CA195765 and R01CA231014 to MCJ; R37AG013925 and R33AG061456 to JLK; P01AG062413 to JLK and LJN; P30AG021334, U01AG020478, U01AG020487, U01AG020480 to SNM; K24AG056589 to SGM; AG043376 and AG056278 LJN; R21CA218732 to KS; R21AG053198 and U01AG057545 to JAS; P30CA008748 to JMS; and R01AG052964 to RT), USDA (Agreement # 58-1950-0-014 and 58-805-9-004 to SNM), the American Cancer Society (CRP 14-111-01-CPPB to WDW), and AKTIV Against Cancer (JMS). Publisher Copyright: © 2020 Published by Oxford University Press.

PY - 2020/4/29

Y1 - 2020/4/29

N2 - Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.

AB - Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.

UR - http://www.scopus.com/inward/record.url?scp=85101687560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101687560&partnerID=8YFLogxK

U2 - 10.1093/jnci/djaa060

DO - 10.1093/jnci/djaa060

M3 - Article

C2 - 32348501

AN - SCOPUS:85101687560

SN - 0027-8874

VL - 113

SP - 112

EP - 122

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 2

ER -

Strategies to Prevent or Remediate Cancer and Treatment-Related Aging

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this